Standard treatment for liver metastases with gastrointestinal stromal tumors
CHEN Lin
LIU Li-cheng
Abstract：Gastrointestinal stromal tumor (GIST) with liver metastases could occur at each risk grade/pathological staging, and seriously affect the survival rate of patients. The rate of liver metastasis from GIST is 15.9%. The treatment for GIST has been an urgent problem in the surgical field. Surgical procedures were important to the patients with GIST. Patients with GIST performed complete tumor resection and taking imatinib postoperatively could have good prognosis. The choice of the surgery ways depends more on the location andsize of tumors. Surgical therapy combined with tyrosine kinase inhibitors (TKI) may be an effective method, and increase the overall survival and improve the quality of survival for patients with liver metastasis significantly. TKI combined surgical treatment is the optimal strategy for GIST with liver metastasis.
Keywords：gastrointestinal stromal tumorliver metastasis
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 399-403 )